Clinical trial
A Prospective, Multi-center, Randomized, Double-blind, Placebo-controlled Study: Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis and an Inadequate Response to Ursodeoxycholic Acid
NCT05751967 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, Randomized, Double-blind, Placebo-controlled Study: Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis and an Inadequate Response to Ursodeoxycholic Acid
- Lead sponsor
- Xijing Hospital of Digestive Diseases
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- February 22, 2023
- Completion date
- December 1, 2027
- Enrollment
- 150 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
primary biliary cholangitis